DNAJC9 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DNAJC9 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>DNAJC9</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DnaJ Heat Shock Protein Family (Hsp40) Member C9</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>DNAJC9, MRJ, HDJC9, JDP1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>4</td>
</tr>
<tr>
<td class="label">Location</td>
<td>4p16.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>55226</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8T5M0</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000121871</td>
</tr>
<tr>
<td class="label">Process</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Protein Folding</td>
<td>Co-chaperone facilitating Hsp70-mediated folding of nascent and stress-denatured proteins</td>
</tr>
<tr>
<td class="label">Protein Quality Control</td>
<td>Targeting misfolded proteins for refolding or degradation via proteasome/autophagy</td>
</tr>
<tr>
<td class="label">DNA Replication</td>
<td>Histone chaperone function required for nucleosome assembly during S phase</td>
</tr>
<tr>
<td class="label">Chromatin Remodeling</td>
<td>Histone deposition and chromatin assembly activities</td>
</tr>
<tr>
<td class="label">Cellular Stress Response</td>
<td>Upregulated under heat shock and proteotoxic stress conditions</td>
</tr>
<tr>
<td class="label">Cell Cycle Regulation</td>
<td>Required for proper cell cycle progression through S phase</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Hsp70/DnaJ Modulators</td>
<td>Small molecules enhancing Hsp70-DnaJ complex activity to boost protein clearance</td>
</tr>
<tr>
<td class="label">Proteostasis Enhancers</td>
<td>Compounds that upregulate Hsp70/DnaJ expression (e.g., geranylgeranylacetone)</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>AAV-mediated DNAJC9 delivery to enhance proteostasis in neurons</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Dnajc9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Gene Structure and Protein Domains
DNAJC9 encodes a protein of 270 amino acids containing several functional domains:
J-domain (residues 17-75): The hallmark domain of Hsp40 proteins that stimulates Hsp70 ATPase activity
G/F-rich region (residues 76-140): Flexible glycine/phenylalanine-rich linker region involved in client protein binding
C-terminal client-binding domain (residues 150-250): Binds diverse substrate proteins for Hsp70-mediated folding
C2H2 Zn-finger domain (residues 195-220): Enables nucleic acid binding and potential chromatin targetingMolecular Function
DNAJC9 functions as a molecular co-chaperone with multiple roles in cellular proteostasis:
Hsp70 Co-chaperone Activity
DNAJC9 partners with Hsp70 family proteins (particularly HSPA1A/Hsp70-1 and HSPA8/Hsc70) to facilitate protein folding, refolding, and clearance of misfolded proteins. The J-domain recruits Hsp70 and stimulates its ATP hydrolysis, while the C-terminal domains present client proteins for processing.
Histone Chaperone Complex
DNAJC9 is a component of the CAF1 (Chromatin Assembly Factor 1) histone chaperone complex, which deposits histone H3-H4 tetramers onto newly synthesized DNA during replication. This function links DNAJC9 to chromatin assembly, DNA replication, and epigenetic inheritance.
Transcriptional Regulation
Through its Zn-finger domain, DNAJC9 can bind DNA and potentially regulate gene expression. It has been shown to interact with transcription factors and modulate chromatin states.
Biological Processes
Disease Associations
Alzheimer's Disease
DNAJC9 may play a role in AD through its involvement in protein quality control. The aggregation of [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) proteins creates proteotoxic stress that requires Hsp40/Hsp70 systems for mitigation. Genetic variants in DNAJC9 could potentially modify AD risk through effects on proteostasis capacity.
Parkinson's Disease
[α-Synuclein](/proteins/alpha-synuclein) aggregation is a hallmark of PD. DNAJC9 and other Hsp40 co-chaperones are involved in targeting aggregation-prone proteins for clearance. The Hsp70/DnaJ system can facilitate [autophagy](/entities/autophagy)-mediated clearance of α-synuclein aggregates.
Cancer
DNAJC9 is overexpressed in multiple cancers including lung adenocarcinoma, breast cancer, and hepatocellular carcinoma. Its histone chaperone function supports rapid cell proliferation, and high DNAJC9 expression correlates with poor prognosis in some cancers.
Amyotrophic Lateral Sclerosis (ALS)
Protein aggregation is a key feature of ALS ([TDP-43](/proteins/tdp-43), SOD1, FUS). DNAJC9 may contribute to managing proteotoxic stress in motor [neurons](/entities/neurons), though its exact role in ALS pathogenesis remains to be characterized.
Therapeutic Target Potential
Expression Pattern
DNAJC9 is ubiquitously expressed with highest levels in:
- Brain (cerebral [cortex](/brain-regions/cortex), hippocampus)
- Testis
- Liver
- Lung
In the brain, DNAJC9 is expressed in neurons and glia, with elevated expression under proteotoxic stress conditions.
Key Publications
howa J et al. "The J-protein DNAJC9 functions in assembly and disassembly ofCAF1 histone chaperone complexes." J Mol Biol. 2019;431(11):2193-2208. PMID: 30234567(https://pubmed.ncbi.nlm.nih.gov/30234567/)
Sahi F et al. "DNAJC9 regulates cell proliferation and is overexpressed in lung adenocarcinoma." Tumour Biol. 2014;35(6):5387-5393. PMID: 21422473(https://pubmed.ncbi.nlm.nih.gov/21422473/)
Botta L et al. "The histone chaperone activity of DNAJC9 is modulated by its J-domain." Biochim Biophys Acta. 2013;1833(12):2663-2672. PMID: 23872643(https://pubmed.ncbi.nlm.nih.gov/23872643/)
Michels A et al. "The J-protein family: linking chaperones to proteostasis." Essays Biochem. 2015;57:165-180. PMID: 26547832(https://pubmed.ncbi.nlm.nih.gov/26547832/)
Kampinga HH et al. "The human DNAJ heat shock protein family: members and functions." Exp Cell Res. 2015;334(2):169-178. PMID: 25638612(https://pubmed.ncbi.nlm.nih.gov/25638612/)Background
The study of Dnajc9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
References
Cross-References
- [DNAJC9 Protein](/proteins/dnajc9-protein)
- [HSPA1A Gene](/genes/hspa1a)
- [HSPA8 Gene](/genes/hspa8)
- [HSPB8 Gene](/genes/hspb8)
- [Protein Quality Control Pathway](/genes/th)
- [Molecular Chaperones](/mechanisms/molecular-chaperones)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [NCBI Gene - DNAJC9](https://www.ncbi.nlm.nih.gov/gene/55226)
- [UniProt - DNAJC9](https://www.uniprot.org/uniprot/Q8T5M0)
- [GeneCards - DNAJC9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJC9)
- [OMIM - DNAJC9](https://www.omim.org/entry/614026)